SCD and Parkinson disease: In Parkinson's disease, increases in monounsaturated fatty acids (MUFA) in phospholipid membranes promote α‐synuclein binding, aggregation, and toxicity, and the inhibition of stearoyl‐CoA desaturase (SCD), the enzyme responsible for synthesizing MUFA, alleviates α‐synuclein toxicity.